SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-013495
Filing Date
2024-04-29
Accepted
2024-04-29 07:49:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A zvra20240429_defa14a.htm DEFA14A 51417
2 picture2.jpg GRAPHIC 14000
  Complete submission text file 0001437749-24-013495.txt   72021
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 24886632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)